Clinical Trial Update: Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of S-Ibuprofen Topical Gel 5% (AP0302) for acute pain from DOMS; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Onset Muscle Soreness
• Pain

Drugs mentioned

• S-Ibuprofen Topical Gel 5% (AP0302) (ibuprofen topical gel)

Snippet

Sponsor: Aponia Laboratories, Inc. | Conditions: Pain, Acute | Phase 2 | Status: COMPLETED | Results posted: 2022-01-25